Carrie Van Der Weyden Selected Research

T-Cell Lymphoma (Lymphoma, T Cell)

5/2021	Targeted Approaches to T-Cell Lymphoma.
1/2021	Pralatrexate in relapsed/refractory T-cell lymphoma: a retrospective multicenter study.
1/2019	Brentuximab vedotin in T-cell lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carrie Van Der Weyden Research Topics

Disease

3	T-Cell Lymphoma (Lymphoma, T Cell) 05/2021 - 01/2019
2	Sezary Syndrome (Sezary Erythroderma) 11/2022 - 01/2017
2	Mycosis Fungoides 11/2022 - 08/2018
2	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2019 - 08/2018
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2019
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2019
1	Coinfection 01/2017
1	Primary Cutaneous Anaplastic Large Cell Lymphoma 01/2017
1	Neoplasms (Cancer) 01/2017

Drug/Important Bio-Agent (IBA)

1	10-propargyl-10-deazaaminopterin FDA Link 01/2021
1	Brentuximab VedotinIBA 01/2019
1	KIR3DL2 ReceptorsIBA 08/2018
1	Monoclonal AntibodiesIBA 08/2018
1	Alemtuzumab (Campath)FDA Link 01/2017

Therapy/Procedure

3	Therapeutics 05/2021 - 01/2017
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 11/2022
1	Art Therapy 01/2017